Heart of England NHS Foundation Trust

Birmingham B9 5SS

0 studies enrolling now · 7 studies all time

What they study most

Anemia, Cystic Fibrosis, HIV, HIV Infections, High Risk Essential Thrombocythemia, High Risk Polycythemia Vera, Multiple Myeloma, Myelofibrosis, Myeloproliferative Disorders, Post-Polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Smoldering Multiple Myeloma

Studies at this site

• An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions — Running, not enrolling
• A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma — Completed
• A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens — Completed
• A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis — Completed
• Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF) — Completed
• Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults — Completed
• Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) — Completed